Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.54 USD | +7.54% |
|
+4.72% | -30.34% |
04/06 | Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses | CI |
09/05 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Trading Ideas